Efficacy of Novel Drug-combinations for Relief of Psoriasis

Paused

Conditions studied: Psoriasis

In brief

ENDURE is a prospective, observational study aimed to document clinical response and side effects associated with compounded psoriasis medications when prescribed as routine care. As a secondary initiative, this study will assess methotrexate systemic absorption and toxicity in patients prescribed a methotrexate-containing compounded formulation.

Key facts

Study ID
NCT02394301
Run by
Medimix Specialty Pharmacy, LLC
People needed
200
Starts
2015-02-01
Expected to finish
2015-12-01
Last updated by the study team
2015-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.